Simultaneous determination of polymorphism in N-acetyltransferase 1 and 2 genes by reverse line blot hybridization

被引:9
作者
Bunschoten, A
Tiemersma, E
Schouls, L
Kampman, E
机构
[1] Univ Wageningen & Res Ctr, Div Human Nutr & Epidemiol, NL-6703 HA Wageningen, Netherlands
[2] Natl Inst Publ Hlth & Environm, Res Lab Infect Dis, NL-3720 BA Bilthoven, Netherlands
关键词
genotyping; allelic variants; NAT; reverse line blot hybridization;
D O I
10.1006/abio.2000.4742
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Polymorphism in N-acetyltransferases NAT1 and NAT2 may contribute to differences in cancer susceptibility of;subjects exposed to alkylating compounds. We developed a robust method for simultaneous determination of these NAT polymorphisms: Reverse line blot (RLB) hybridization, based on PCR followed by allele-specific oligo hybridization. On a membrane, allele-specific oligonucleotide probes of the NAT genes (NAT1*4,*3, *10, *11 and NAT2*4, *5, *6, *7, *12) were applied in lines. After separate amplification of the NAT genes, simultaneous hybridization of these products in lines perpendicular to the lines with oligonucleotide probes was performed, followed by nonradioactive detection. This resulted in hybridization patterns, representing the NAT genotype of an individual. RLB hybridizations were conducted on DNA from 240 Dutch Caucasian participants in an ongoing case-control study on colorectal adenoma (including 126 polyp-free control subjects). Results were in complete agreement with those obtained by commonly used methods, i.e., allele-specific PCR and PCR-RFLP. Allele-frequencies in the polyp-free control group were similar to those described in the literature. RLB hybridization is, however, considerably faster and cheaper than the common assays. Moreover, expansion with,allelic variants of other genes is relatively easy, which makes RLB hybridization very useful for multiplex analysis of numerous polymorphisms in epidemiological studies. (C) 2000 Academic Press.
引用
收藏
页码:156 / 162
页数:7
相关论文
共 15 条
[1]  
BELL DA, 1995, CANCER RES, V55, P3537
[2]   GENOTYPE-PHENOTYPE DISCORDANCE FOR HUMAN ARYLAMINE N-ACETYLTRANSFERASE (NAT2) REVEALS A NEW SLOW-ACETYLATOR ALLELE COMMON IN AFRICAN-AMERICANS [J].
BELL, DA ;
TAYLOR, JA ;
BUTLER, MA ;
STEPHENS, EA ;
WIEST, J ;
BRUBAKER, LH ;
KADLUBAR, FF ;
LUCIER, GW .
CARCINOGENESIS, 1993, 14 (08) :1689-1692
[3]   Determination of human NAT2 acetylator genotype by oligonucleotide ligation assay [J].
Bigler, J ;
Chen, C ;
Potter, JD .
BIOTECHNIQUES, 1997, 22 (04) :682-&
[4]   Identification of N-acetyltransferase 2 genotypes by continuous monitoring of fluorogenic hybridization probes [J].
Blömeke, B ;
Sieben, S ;
Spötter, D ;
Landt, O ;
Merk, HF .
ANALYTICAL BIOCHEMISTRY, 1999, 275 (01) :93-97
[5]   HUMAN ARYLAMINE N-ACETYLTRANSFERASE GENES - ISOLATION, CHROMOSOMAL LOCALIZATION, AND FUNCTIONAL EXPRESSION [J].
BLUM, M ;
GRANT, DM ;
MCBRIDE, W ;
HEIM, M ;
MEYER, UA .
DNA AND CELL BIOLOGY, 1990, 9 (03) :193-203
[6]   N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk [J].
Bouchardy, C ;
Mitrunen, K ;
Wikman, H ;
Husgafvel-Pursiainen, K ;
Dayer, P ;
Benhamou, S ;
Hirvonen, A .
PHARMACOGENETICS, 1998, 8 (04) :291-298
[7]  
CASCORBI I, 1995, AM J HUM GENET, V57, P581
[8]  
CASCORBI I, 1996, CANCER RES, V56, P391
[9]   DETERMINATION OF HUMAN NAT2 ACETYLATOR GENOTYPE BY RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM AND ALLELE-SPECIFIC AMPLIFICATION [J].
DOLL, MA ;
FRETLAND, AJ ;
DEITZ, AC ;
HEIN, DW .
ANALYTICAL BIOCHEMISTRY, 1995, 231 (02) :413-420
[10]  
Hirvonen A.In:., 1999, Metabolic polymorphisms and susceptibility to cancer, P251